drugset / Trial / NCT01459276

A Study to Evaluate Safety and Immunogenicity of FluvalAB-like Influenza Vaccine in Non-Elderly Adult and Elderly Subjects

NCT01459276 ↗

Completed 1206 enrolled Fluart Innovative Vaccine Ltd, Hungary
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to determine the immunogenicity and tolerability of one 0.5 mL intramuscular (IM) injection of FLUVAL AB-like trivalent influenza vaccine containing 6μgHA of seasonal A/H1N1, A/H3N2 and B influenza antigens in adults and elderly people.

Timeline

Start
2011-10
Primary completion
2011-12
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject FAB-6011 Vaccine 0.5 ml Intramuscular
Comparator Fluval AB Vaccine 0.5 ml Intramuscular

Indications